Eko Low Ejection Fraction Tool (ELEFT) vs TeraRecon Cardiac.Chambers.MR

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Tool A is an AI-powered screening tool that integrates with digital stethoscopes for the early detection of low ejection fraction during routine physical exams. In contrast, Tool B is an AI solution for the automatic segmentation and volumetric analysis of cardiac chambers from MR images, primarily aiding in detailed diagnosis and treatment planning. While both address cardiac health and ejection fraction, they operate on different data modalities and serve distinct purposes within the clinical workflow.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Frequently Asked Questions

How does each tool specifically integrate into a physician's existing clinical workflow, and what are the primary clinical scenarios where each tool provides the most value (e.g., screening vs. definitive diagnosis)?

Eko Low Ejection Fraction Tool (ELEFT) integrates into routine physical exams, providing rapid, non-invasive screening for low ejection fraction using a digital stethoscope, making it suitable for early identification of heart failure risk in primary care or initial cardiology assessments. TeraRecon Cardiac.Chambers.MR is designed for post-imaging analysis, automatically segmenting cardiac chambers from MR images to aid in diagnosis and treatment planning, and is best utilized by cardiologists and radiologists for detailed cardiac assessment following an MR study.

What is the depth of EHR integration for each tool, and how are the AI-generated results or reports automatically transferred and presented within a patient's electronic health record?

Eko Low Ejection Fraction Tool (ELEFT) integrates with Eko digital stethoscopes and utilizes cloud-based data processing and storage. While it aids in detection, the specific depth of automated result transfer directly into an EHR beyond the Eko platform is not detailed in the provided information. TeraRecon Cardiac.Chambers.MR outputs results as DICOM files for interoperability with PACS and other systems, suggesting a robust integration pathway for imaging data and reports into existing radiology and cardiology IT infrastructure, which can then link to EHRs.

What are the reported accuracy, sensitivity, and specificity metrics for each tool in detecting low ejection fraction or segmenting cardiac chambers, and how do these compare to current diagnostic standards?

Eko Low Ejection Fraction Tool (ELEFT) was clinically validated with a sensitivity of 74.7% and a specificity of 77.5% for the detection of left ventricular ejection fraction (LVEF) less than 40%. TeraRecon Cardiac.Chambers.MR provides automatic segmentation of cardiac chambers and volumetric analysis of ejection fraction from MR images to assist in diagnosis and treatment planning. However, specific accuracy or performance metrics for its segmentation functions are not detailed in the provided information.

What is the expected learning curve for physicians to become proficient in using each tool and confidently interpreting its outputs in their daily practice?

Given Eko Low Ejection Fraction Tool (ELEFT)'s integration with a familiar medical device (digital stethoscope) and its rapid, automated analysis providing results in approximately 15 seconds, the learning curve for physicians to incorporate it into routine physical exams is likely to be relatively low. For TeraRecon Cardiac.Chambers.MR, physicians already proficient in interpreting cardiac MR images would primarily need to familiarize themselves with the AI's interface for automatic segmentation and volumetric analysis, and how to leverage the DICOM outputs within their existing imaging review workflows.

Beyond standard compliance, what specific security measures are implemented to protect patient data, and what audit-trail features are available to track the use and results of the AI algorithms?

Eko Low Ejection Fraction Tool (ELEFT) utilizes cloud-based data processing and storage and is HIPAA compliant. However, specific advanced security measures beyond standard compliance or explicit audit-trail features for tracking AI-generated insights are not detailed in the provided information. TeraRecon describes strict data confidentiality procedures for Protected Health Information (PHI) and assists customers with data security compliance. While outputting DICOM files can aid in tracking within imaging systems, specific audit-trail capabilities for the AI's analytical process are not explicitly outlined.

For healthcare systems with multiple sites, what are the considerations for a consistent rollout of each tool, and what level of implementation and ongoing support is provided?

Eko Low Ejection Fraction Tool (ELEFT) is part of Eko's SENSORAu2122 platform, an enterprise solution, suggesting a structured approach for multi-site deployment. However, specific considerations for consistent rollout across different locations or dedicated implementation and ongoing support mechanisms are not detailed. TeraRecon Cardiac.Chambers.MR is available as a containerized application and on a robust cloud-based SaaS platform, which typically supports scalable deployments across multiple sites. TeraRecon also provides customer service and user manuals for support.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

Backers

Who funded each tool's parent company.